GlaxoSmithKline Pharmaceuticals board to consider unaudited financial results

08 Apr 2014 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on April 17, 2014, to consider approval of unaudited financial results for the quarter ended March 31, 2014 (Q1).

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2504.35 31.10 (1.26%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.